Noble Financial Cuts Bacterin International (BONE) to Hold Following Concerning Outlook
Tweet
Share
E-mailGet Alerts BONE Hot Sheet
Price: $3.25 --0%
Rating Summary:
3 Buy, 0 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
3 Buy, 0 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Noble Financial downgraded shares of Bacterin International (NYSE: BONE) from Buy to Hold in an intraday research note Friday.
The downgrade follows Q1 results and the resulting 19 percent decline in the stock.
The company posted a quarterly loss of 3 cents per share and reduced its FY13 sales guidance from $53-$56 million to $35-$40 million. Analysts on the Street are currently expecting sales of $79.9 million.
For an analyst ratings summary and ratings history on Bacterin International click here. For more ratings news on Bacterin International click here.
Shares of Bacterin International closed at $1.77 yesterday.
The downgrade follows Q1 results and the resulting 19 percent decline in the stock.
The company posted a quarterly loss of 3 cents per share and reduced its FY13 sales guidance from $53-$56 million to $35-$40 million. Analysts on the Street are currently expecting sales of $79.9 million.
For an analyst ratings summary and ratings history on Bacterin International click here. For more ratings news on Bacterin International click here.
Shares of Bacterin International closed at $1.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- Gordon Haskett cuts TJX Companies rating to Accumulate
- UBS Downgrades Merck (MRK) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Noble FinancialSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
